296 related articles for article (PubMed ID: 35379124)
1. Identification of Hub Genes and Biomarkers between Hyperandrogen and Normoandrogen Polycystic Ovary Syndrome by Bioinformatics Analysis.
Zhang T; Liu Y; Li X; Hu B
Comb Chem High Throughput Screen; 2023; 26(1):126-134. PubMed ID: 35379124
[TBL] [Abstract][Full Text] [Related]
2. Exploration of hub genes involved in PCOS using biological informatics methods.
Zhou F; Xing Y; Cheng T; Yang L; Ma H
Medicine (Baltimore); 2022 Oct; 101(40):e30905. PubMed ID: 36221354
[TBL] [Abstract][Full Text] [Related]
3. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.
Devarbhavi P; Telang L; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
Reprod Biol Endocrinol; 2021 Feb; 19(1):31. PubMed ID: 33622336
[TBL] [Abstract][Full Text] [Related]
4. Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome.
Chen Y; Ma L; Ge Z; Pan Y; Xie L
Front Mol Biosci; 2022; 9():888194. PubMed ID: 35693550
[No Abstract] [Full Text] [Related]
5. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential biomarkers of vascular calcification using bioinformatics analysis and validation
Chen C; Wu Y; Lu HL; Liu K; Qin X
PeerJ; 2022; 10():e13138. PubMed ID: 35313524
[TBL] [Abstract][Full Text] [Related]
7. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Wu J; Lv Q; Huang H; Zhu M; Meng D
Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
[No Abstract] [Full Text] [Related]
8. Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy.
Zhang H; Huo J; Jiang W; Shan Q
Mol Med Rep; 2020 Aug; 22(2):915-925. PubMed ID: 32626989
[TBL] [Abstract][Full Text] [Related]
9. Identification of Differentially Expressed Genes and Signaling Pathways in Acute Myocardial Infarction Based on Integrated Bioinformatics Analysis.
Chen DQ; Kong XS; Shen XB; Huang MZ; Zheng JP; Sun J; Xu SH
Cardiovasc Ther; 2019; 2019():8490707. PubMed ID: 31772617
[TBL] [Abstract][Full Text] [Related]
10. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
11. Identification of Potential Genetic Biomarkers and Target Genes of Peri-Implantitis Using Bioinformatics Tools.
Zhang X; Wang Z; Hu L; Shen X; Liu C
Biomed Res Int; 2021; 2021():1759214. PubMed ID: 34931168
[TBL] [Abstract][Full Text] [Related]
12. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
Liu J; Cheng Z
Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
14. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses.
Tang D; Zhao X; Zhang L; Wang Z; Wang C
J Cell Biochem; 2019 Jun; 120(6):9522-9531. PubMed ID: 30506958
[TBL] [Abstract][Full Text] [Related]
15. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis.
Cheng Q; Chen X; Wu H; Du Y
J Transl Med; 2021 Jan; 19(1):18. PubMed ID: 33407587
[TBL] [Abstract][Full Text] [Related]
16. Identification of Crucial lncRNAs, miRNAs, mRNAs, and Potential Therapeutic Compounds for Polycystic Ovary Syndrome by Bioinformatics Analysis.
Zeng Z; Lin X; Xia T; Liu W; Tian X; Li M
Biomed Res Int; 2020; 2020():1817094. PubMed ID: 33224973
[TBL] [Abstract][Full Text] [Related]
17. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.
Chen B; Sun D; Qin X; Gao XH
Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609
[TBL] [Abstract][Full Text] [Related]
18. Identification of hub genes and regulatory networks in histologically unstable carotid atherosclerotic plaque by bioinformatics analysis.
Guo J; Ning Y; Su Z; Guo L; Gu Y
BMC Med Genomics; 2022 Jun; 15(1):145. PubMed ID: 35773742
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics-based analysis of potential therapeutic target genes for polycystic ovary syndrome.
Liu Y; Yu J; Li J; Li W; Ma H
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):169-175. PubMed ID: 38678611
[TBL] [Abstract][Full Text] [Related]
20. Screening Key Genes and Biological Pathways in Nasopharyngeal Carcinoma by Integrated Bioinformatics Analysis.
Tai J; Park J; Han M; Kim TH
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]